Compounds > 3,4-dihydroxyphenylacetaldehyde
Page last updated: 2024-09-03

3,4-dihydroxyphenylacetaldehyde and acetylcysteine

3,4-dihydroxyphenylacetaldehyde has been researched along with acetylcysteine in 2 studies

Compound Research Comparison

Studies
(3,4-dihydroxyphenylacetaldehyde)		Trials
(3,4-dihydroxyphenylacetaldehyde)		Recent Studies (post-2010)
(3,4-dihydroxyphenylacetaldehyde)		Studies
(acetylcysteine)		Trials
(acetylcysteine)		Recent Studies (post-2010) (acetylcysteine)
9905014,5801,0465,960

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Goldstein, DS; Isonaka, R; Jinsmaa, Y; Sharabi, Y; Sullivan, P1
Goldstein, DS; Isonaka, R; Jinsmaa, Y; Sharabi, Y1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and acetylcysteine

ArticleYear
3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by
    The Journal of pharmacology and experimental therapeutics, 2018, Volume: 366, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Humans; Intracellular Space; Oxidation-Reduction; PC12 Cells; Protein Multimerization; Protein Structure, Quaternary; Proteins; Proteolysis; Quinones; Rats

2018
3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing
    The Journal of pharmacology and experimental therapeutics, 2020, Volume: 372, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; alpha-Synuclein; Antioxidants; Cell Line; Copper; Dopamine; Humans; Monoamine Oxidase; Monophenol Monooxygenase; Oligodendroglia; Oxidation-Reduction; Parkinson Disease; Protein Binding; Protein Conformation; Tolcapone

2020